Post-marketing safety of anti-IL-5 monoclonal antibodies (mAbs): an analysis of the FDA Adverse Event Reporting System (FAERS)
Article in Expert Opinion on Drug Safety (August 2023)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Article in Expert Opinion on Drug Safety (August 2023)
Article in Clinical and Experimental Medicine (August 2023)
Article in Proceedings of Scientific Research Universidad Anáhuac Multidisciplinary Journal of Healthcare (June 2023)